These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3875804

  • 21. Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTP.
    Zimmer J, Geneser FA.
    Neurosci Lett; 1987 Aug 05; 78(3):253-8. PubMed ID: 3498133
    [Abstract] [Full Text] [Related]

  • 22. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.
    Riachi NJ, Harik SI.
    Life Sci; 1988 Aug 05; 42(23):2359-63. PubMed ID: 3259663
    [Abstract] [Full Text] [Related]

  • 23. Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B.
    Da Prada M, Cesura AM, Kettler R, Zürcher G, Haefely WE.
    Neurosci Lett; 1985 Jun 24; 57(3):257-62. PubMed ID: 3875815
    [Abstract] [Full Text] [Related]

  • 24. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M.
    J Pharmacol Exp Ther; 1986 Aug 24; 238(2):648-52. PubMed ID: 3488394
    [Abstract] [Full Text] [Related]

  • 25. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.
    Chiba K, Trevor A, Castagnoli N.
    Biochem Biophys Res Commun; 1984 Apr 30; 120(2):574-8. PubMed ID: 6428396
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Quirion R, Welner S, Gauthier S, Bédard P.
    Synapse; 1987 Apr 30; 1(6):559-66. PubMed ID: 2843996
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Castagnoli N, Chiba K, Trevor AJ.
    Life Sci; 1985 Jan 21; 36(3):225-30. PubMed ID: 3871243
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP.
    Proc Natl Acad Sci U S A; 1988 Aug 21; 85(16):6172-6. PubMed ID: 3137566
    [Abstract] [Full Text] [Related]

  • 40. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G, Nwanze E, Luthman J, Sundström E.
    Acta Physiol Scand; 1986 Oct 21; 128(2):187-94. PubMed ID: 3535380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.